Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients.

Song, Peng; Zhang, Dingding; Cui, Xiaoxia; Zhang, Li

Song, Peng; Zhang, Dingding; Cui, Xiaoxia; Zhang, Li.

Afiliação

Song P; Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
Zhang D; Central Research Laboratory,Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
Cui X; Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
Zhang L; Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.

Thorac Cancer ; 11(9): 2406-2430, 2020 09.

Article em En | MEDLINE | ID: mdl-32643323

Assuntos

Inibidores de Checkpoint Imunológico/efeitos adversos; Neoplasias/complicações; Neoplasias/tratamento farmacológico; Feminino; Humanos; Masculino; Neoplasias/patologia

Palavras-chave

Cancer; immune checkpoint inhibitor (ICI); immune-related adverse events (irAEs)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Thorac Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Singapura

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google